Malignant B Cells at the Helm in Follicular Lymphoma

被引：8

作者：

Ansell, Stephen M. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN 55905 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 21期

关键词：

NON-HODGKIN-LYMPHOMA; REGULATORY T-CELLS; EXPRESSION;

D O I：

10.1200/JCO.2013.49.2165

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2641 / 2642

页数：2

共 13 条

[1] Programmed Death Ligand 1 Is Expressed by Non-Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells [J].

Andorsky, David J. ;

Yamada, Reiko E. ;

Said, Jonathan ;

Pinkus, Geraldine S. ;

Betting, David J. ;

Timmerman, John M. .

CLINICAL CANCER RESEARCH, 2011, 17 (13) :4232-4244

[2] Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients [J].

Ansell, Stephen M. ;

Maurer, Matthew J. ;

Ziesmer, Steven C. ;

Slager, Susan L. ;

Habermann, Thomas M. ;

Link, Brian K. ;

Witzig, Thomas E. ;

Macon, William R. ;

Dogan, Ahmet ;

Cerhan, James R. ;

Novak, Anne J. .

AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (09) :865-869

[3] Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions [J].

Curran, Kevin J. ;

Pegram, Hollie J. ;

Brentjens, Renier J. .

JOURNAL OF GENE MEDICINE, 2012, 14 (06) :405-415

[4] Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells [J].

Dave, SS ;

Wright, G ;

Tan, B ;

Rosenwald, A ;

Gascoyne, RD ;

Chan, WC ;

Fisher, RI ;

Braziel, RM ;

Rimsza, LM ;

Grogan, TM ;

Miller, TP ;

LeBlanc, M ;

Greiner, TC ;

Weisenburger, DD ;

Lynch, JC ;

Vose, J ;

Armitage, JO ;

Smeland, EB ;

Kvaloy, S ;

Holte, H ;

Delabie, J ;

Connors, JM ;

Lansdorp, PM ;

Ouyang, Q ;

Lister, TA ;

Davies, AJ ;

Norton, AJ ;

Muller-Hermelink, HK ;

Ott, G ;

Campo, E ;

Montserrat, E ;

Wilson, WH ;

Jaffe, ES ;

Simon, R ;

Yang, LM ;

Powell, J ;

Zhao, H ;

Goldschmidt, N ;

Chiorazzi, M ;

Staudt, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2159-2169

[5] How do CARs work? Early insights from recent clinical studies targeting CD19 [J].

Davila, Marco L. ;

Brentjens, Renier ;

Wang, Xiuyan ;

Riviere, Isabelle ;

Sadelain, Michel .

ONCOIMMUNOLOGY, 2012, 1 (09) :1577-1583

[6] Follicular Lymphoma Cells Induce Changes in T-Cell Gene Expression and Function: Potential Impact on Survival and Risk of Transformation [J].

Kiaii, Shahryar ;

Clear, Andrew J. ;

Ramsay, Alan G. ;

Davies, Derek ;

Sangaralingam, Ajanthah ;

Lee, Abigail ;

Calaminici, Maria ;

Neuberg, Donna S. ;

Gribben, John G. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (21) :2654-+

[7] Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia [J].

Porter, David L. ;

Levine, Bruce L. ;

Kalos, Michael ;

Bagg, Adam ;

June, Carl H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) :725-733

[8] B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders [J].

Wilcox, Ryan A. ;

Feldman, Andrew L. ;

Wada, David A. ;

Yang, Zhi-Zhang ;

Comfere, Nneka I. ;

Dong, Haidong ;

Kwon, Eugene D. ;

Novak, Anne J. ;

Markovic, Svetomir N. ;

Pittelkow, Mark R. ;

Witzig, Thomas E. ;

Ansell, Stephen M. .

BLOOD, 2009, 114 (10) :2149-2158

[9] CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intraturnoral CD4+CD25- T cells [J].

Yang, Zhi-Zhang ;

Novak, Anne J. ;

Ziesmer, Steven C. ;

Witzig, Thomas E. ;

Ansell, Stephen M. .

BLOOD, 2007, 110 (07) :2537-2544

[10] Attenuation of CD8+ T-cell function by CD4+CD25+ regulatory T cells in B-cell non-Hodgkin's lymphoma [J].

Yang, Zhi-Zhang ;

Novak, Anne J. ;

Ziesmer, Steven C. ;

Witzig, Thomas E. ;

Ansell, Stephen M. .

CANCER RESEARCH, 2006, 66 (20) :10145-10152

← 1 2 →